Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian M Waszak

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
EMBO Molecular Medicine|August 6, 2020
Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursorsBüşra Erarslan-Uysal, Joachim B Kunz, Tobias Rausch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
Science (New York, N.Y.)|October 19, 2013
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcriptionHelena Kilpinen, Sebastian M Waszak, Andreas R Gschwind, et al.
Neuro-Oncology|February 14, 2022
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomasJustyna M Przystal, Chiara Cianciolo Cosentino, Sridevi Yadavilli, et al.
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Journal of Medical Genetics|June 29, 2022
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working GroupLéa Guerrini-Rousseau, Julien Masliah-Planchon, Sebastian M Waszak, et al.
JCI Insight|February 25, 2021
Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lungMaria Llamazares-Prada, Elisa Espinet, Vedrana Mijošek, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumorsRyan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
Nature Communications|November 21, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumorsRyan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
EMBO Molecular Medicine|August 6, 2020
Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursorsBüşra Erarslan-Uysal, Joachim B Kunz, Tobias Rausch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
Science (New York, N.Y.)|October 19, 2013
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcriptionHelena Kilpinen, Sebastian M Waszak, Andreas R Gschwind, et al.
Neuro-Oncology|February 14, 2022
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomasJustyna M Przystal, Chiara Cianciolo Cosentino, Sridevi Yadavilli, et al.
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Journal of Medical Genetics|June 29, 2022
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working GroupLéa Guerrini-Rousseau, Julien Masliah-Planchon, Sebastian M Waszak, et al.
JCI Insight|February 25, 2021
Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lungMaria Llamazares-Prada, Elisa Espinet, Vedrana Mijošek, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumorsRyan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
Nature Communications|November 21, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumorsRyan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, et al.
Pageof 8